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TISSUE CULTURE STUDIES ON HUMAN SKIN
IV. THE COMPARATIVE Toxic EFFECTS OF ANTIBiOTICS ON TISSUE CULTURE
EXPLANTS OF HUMAN SKIN AND EMBRYONIC CHICK SPLEEN*
FUNAN HE, M.D., CLARENCE S. LIVINGOOD, M.D., PATRICIA JOHNSON, B.S.
AND CHARLES M. POMERAT, Pu.D.
One of the essential procedures in the study of antibiotics, as well as other medicaments
which are to be used as topical therapeutic agents, is the determination of the safe concen-
tration of a given drug which may be used in the topical treatment of diseases of the skin
and mucous membranes. Consideration of the safe topical dose of a therapeutic agent must
take into account its primary irritant properties, its capacity for sensitizing the skin on
repented application, and possible systemic toxic effects which may occur dne to absorption.
In this study, we were concerned only with the primary irritant producing capacity of
antibiotics.
In a preceding paper (1), we reported the in vitro toxic effect on human epithelium of
eight drugs which may be applied to the skin for the treatment of certain skin diseases.
During the past eighteen months, this work has been extended to include various groups of
therapeutic agents which may be used for the local treatment of skin diseases. This has
been done in order to explore further the possibility of developing a satisfactory laboratory
method for determining the potential irritancy of various drugs, chemicals, and antibiotics
which are of proven or potential value in the treatment of cutaneous diseases. The present
study is in regard to the comparative in vitro toxic effect of thirteen different antibiotics on
human skin explants and embryonic chick spleen growing in tissue culture.
The primary irritant-producing capacity of a given drug, chemical, or antibiotic may
be determined by patch testing a suitable number of subjects, using various concentrations
ranging from 0.1% or less to the pure substance. This method is satisfactory for detecting
gross irritancy of the material for intact skin at one particular site of the cutaneous surface
under the conditions of the test, which is usually a closed patch test applied for a period of
24 to 48 hours. Using this method, it is not difficult to determine that a highly irritant drug
or chemical, such as mercury bichloride, has a capacity for definite irritation of the skin on
contact because one application of a 1% aqueous solution of the chemical will produce ob-
vious irritation of intact human skin in almost every case, whereas 0.1% aqueous solution
does not cause irritation. Therefore, it becomes obvious that the safe topical dose of this
medicament is of the order of 0.1% or less. However, this method is not satisfactory for
predicting borderline irritant effects which may he manifest only under circumstances
which are favorable for the development of irritation, such as a breakdown in the skin
barrier encountered as a result of maceration due to climatic conditions or partial denuda-
tion of the epithelium. In many instances, numerous tests under various conditions, using
a large number of subjects, will not yield accurate, conclusive results. It is essential to
depend on clinical experience which is accumulated by applying the topical therapeutic
agent to the affected sites of patients with various diseases of the skin and mucous mem-
branes. It is obvious that the collection of such data is a slow process, and indeed the ac-
curate evaluation of a new drug in this respect may involve the accumulation of experience
for as long as several years.
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It is necessary to emphasize that this tissue culture technic, which is proposed as a pos-
sible laboratory method for estimating the safe topical dose of a drug, does not refer to the
possible estimation of the allergenic capacity or sensitizing index of the medieament. If
there is a correlation between in vitro toxic effects of therapeutic agents on epithelial cells
in tissue culture and in vivo effects when in contact with the skin, it would apply only in
regards to the primary irritant producing capacity of the medicaments. The irritant ca-
pacity of a given drug or chemical may or may not be related to its sensitizing potential.
In general, prolonged irritation of the skin which is caused by the application of a given
drug or chemical tends to lead to eventual sensitization to that particular substance; in-
deed, under these circumstances, there is an increased tendency for the injured skin to
become sensitized to numerous other contactants. However, the prolonged application of
other topical medicaments which are not irritating even for abraded or inflamed skin may
result in the sensitization of a significant percentage of patients. For example, the local
application of penicillin is accompanied by a cutaneous sensitivity reaction in a compara-
tively high percentage of patients despite the fact that this antibiotic is unusually well
tolerated by all types of tissue and does not cause primary irritation when applied to intact
or diseased skin. On the other hand, certain acids nnd alkalis which are primary irritants
in low concentrations are not sensitizers.
Numerous investigators have used tissue culture technics in testing the potential toxicity
of antibiotics. Herrell and Heilman (2, 3), Gey et al. (4), Cornman (5, 6), and Bueher (7, 8,
0, 10) have reported that penicillin is relatively non-toxic for rabbit lymph node, normal
and tumor cells of rat and rabbit, and dog fibroblasts. The in vitro toxicity of Chloromycetin,
Aureomycin and Streptomycin for embryonic chick fibroblasts has been studied by Keilova-
Rodova (11, 12, 13) with results which indicate that these antibiotics are comparatively
non-toxic and, more specifically, that Chloromycetin is more toxic than Aureomycin and
Streptomycin. The work of Lepine et al. (14) tends to confirm that of Keilova-Rodova in
that they found Aureomycin less inhibitory for the outgrowth of embryonic chick brain
tissue than Chloromyeetin. The results of Ikegaki (15) indicated comparatively low in vitro
toxicity of Streptomycin for various tissues of the chick embryo; Barski (16), using rat
lung tissue, reported similar results for Streptomycin. The extensive studies of Herrell and
his co-workers (2, 3, 17) included a comparison of the in vitro toxicity of Peni-
cillin, Tyroeidin, Gramicidin, and other non-antibiotic antibacterial agents, including
Merthiolate, Zephiran, and Phemerol; they stated that Gramicidin and Tyrocidin were
definitely more toxic than Penicillin but that these antibiotics were less toxic than the
other antibacterial agents which were tested; lymph node and spleen were the test tissues
used in these studies.
As far as we known, however, there are no reports in the literature concerning the in vitro
toxic effect of antibiotics for explants of adult human skin growing in tissue culture.
MATERIALS AND METHODS
Adult human skin used in this study was obtained from the Department of
Plastic Surgery as pieces left over from skin grafting procedures. The tissue cul-
ture technic employed \vas similar to that which has been reported by Lewis,
Pomerat, and Ezell (18) and described in detail in the authors' previous publica-
tions (1, 19). The method is illustrated diagrammatically in a recent paper (19)
which was published in this journal. The essential steps in this procedure were as
follows:
1. Fragments approximately 2 mm. square were cut for explanting.
2. These fragments were imbedded in a clot composed of one drop of cockerel
plasma (containing 1000 gamma of penicillin G sodium per ml. of culture
medium for control cultures) and one drop of embryonic extract containing
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the antibiotic to be tested. If an antibiotic or other antibacterial agent is
not added, a high percentage of these skin cultures tend to become con-
taminated despite careful aseptic technic.
3. After the clot had set firmly, four drops of human ascitic fluid, obtained from
patients with metastatic carcinoma, were added.
4. The clots were made on 1 square sterile cover glasses, and after ascitic
fluid was added, they were mounted on a hanging drop slide, sealed with
hot paraffin wax and incubated at 37°C for eight days. Cultures were
examined daily or every two days until the eighth day.
Generally, outgrowth was observed to appear within 48 to 72 hours, reaching
a maximum on the 5th or 7th day. The extent of migration of epithelial cells
was graded by estimating the amount of the low power field it covered. The min-
imal inhibitory dose (MID) and least injurious dose (LID) were determined for
each antibiotic.
This was done according to the method previously described (1, 19), i.e., in-
creasing concentrations of the antibiotic to be tested were added to the medium
in which the skin explants were imbedded until the smallest quantity required
to effect first evidence of injury as compared to an untreated control was deter-
mined; this quantity was designated as the least injurious dose or LID. Similar
titrations indicated the smallest quantity required to produce total inhibition of
outgrowth; this quantity was labeled as the minimal inhibitory dose or MID.
Occasionally, preparations were fixed with methyl alcohol and stained accord-
ing to Jacobson's method (20) in order to preserve records of unusual types of
outgrowth.
In all routine tests, the antibiotics were mixed with embryonic juice and
incorporated in the plasma clot. It was assumed that the drugs diffused freely
through the loose interstices of the clot, permitting intimate contact with the
nutrient fluid phase, thus resulting in an equal concentration throughout the
preparation. Apparent confirmation of this assumption was established by check
experiments which were made at critical points in the evaluation of each anti-
biotic. This involved the introduction of the antibiotics both in the clot and in the
fluid medium; under these circumstances, the results were identical with those
obtained in the routine procedure.
For determining final critical values, experiments were repeated at least three
times and, in some instances, on as many as ten to fifteen different days. In this
way, the comparative toxicity of the various antibiotics in relation to uniform
explants and media could be evaluated. Moreover, day-to-day chance variations
in the composition of media and in the behavior of samples of skin from individual
patients which were utilized could be controlled.
For comparison, toxicity of these antibiotics for embryonic chick spleen ex-
plants was determined. The technic was essentially the same as that used for
the cultivation of skin except that ascitic fluid was not added to the plasma clot.
All spleen explants were obtained from chick embryos which had incubated for
17 to 20 days. Cultures were examined and the final results recorded at the end of
24 hours. Ratings of outgrowth followed the system outlined by Pomerat (21).
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TABLE I
Toxicity in gamma per ml. of cutture medium of various antibiotics to explants of human skin
NUMBER OF NUMBER OF LID MIDANTIBIOTIC CULTURES EXFEEIMENTS
Panicillin G Sodium
Penicillin G Potassium
150
385
S
23
1,250—2,500
1,500—1,875
5,000—10,000
2,000—3,750
Bacitracin 265 16 830—1,665 5,000—10,000
Neomycin Sulfate 455 21 830—1,015 4,165—6,250
SKF-1714-J (Nco-Penil) 135 9 830—1,250 2,500_*t
Penicillin 0 155 9 625—1,250 2,500—5,000
Circulin 210 12 415—830 3,330—5,000
Streptomycin 230 12 210—415 2,220—6,665
Chloromycetin 245 16 135—275 555—830
Polymyxin B Sulfnte 255 15 105—210 830-1,665
AureomycinHCl & sod. glycinata.. 335 18 105—210 830—1,250
Terramycin HC1 & sod. glycin-
ate 285 12 50—100 520—1,040
Chloromycetin & glycine 210 10 50—100 415—830
Endomycin 290 10 50—100 250—500
Terramycin HC1 130 6 25—50 100—200
Gramicidin 325 12 0.1—0.2 0.5—1.0
* Higher concentrations could not be obtained duo to 'ow solubility.
t Marked inhibition, very close to complete inhibition.
TABLE II
Toxicity in gamma per ml. of culture medium of various antibiotics to explants of embryonic
chick spleen
ANTIBIOTSC NUSIBEROF EXFEEIMENTS LID MID
Penicillin G Sodium 85 8 940—1,875 75,000—150,000
Circulin 55 6 2,500—5,000 20,000_*
Penicillin 0 85 8 1,875—3,750 150,000—300,000
Neomycin Sulfate 120 12 780—1,560 250,000—500,000
Bacitracin 125 10 625—1,250 20,000—st
Polymyxin B Sulfate 140 11 310—625 10,000_*t
Terramycin HC1 & sod. glycin-
ate 65 8 250—500 50,000_*t
Chloromycetin 100 8 165—330 1,665—3,330
Streptomycin 190 13 155—310 300,000_*t
SKF-1714-J (Neo-Penil) 50 6 155—310 5,000_*f
AureomycinHCl & sod. glycinate.. 115 4 155—310 5,000_*f
Chloromycetin with glycine 100 9 125—250 2,500—5,000
Endomycin 125 10 100—200 2,500—5,000
Gramicidin 80 6 5—10 500_*t
* Higher concentrations could not be obtained due to low solubility.
f Marked inhibition, close to complete inhibition.
t Partial inhibition.
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TABLE III
Concentrations of antibiotics in gammas per ml. of culture media
ANTIBIOTIC TISSUE LID MID
Penicillin G Sodium Chick spleen 940—1,875 75,000-150,000
Human skin 1,250—2,500 5,000—10,000
Penicillin G Potassium Human skin 1,500—1,875 2,000—3,750
Bacitracin Chick spleen 625—1,250 20,000*1:
Human skin 830—1,665 5,000—10,000
Neomycin Sulfate Chick spleen 780—1,560 250,000—500,000
Human skin 830 1,015 4,165—6,250
SKF-1714-J (Neo-Penil) Chick spleen 155—310 5,000_*f
Human skin 830—1,250 2,500_*t
Penicillin 0 Chick spleen 1,875 3,750 150,000—300,000
Human skin 625—1,250 2,500—5,000
Circulin Chick spleen 2,500—5,000 20,000_*
Human skin 415—830 3,330—5,000
Streptomycin Chick spleen 155—310 300,000_*t
Human skin 210—415 2,220—6,665
Chloromycetin Chick spleen 165—330 1,665-3,330
Human skin 135—275 555—830
Polymyxin B Sulfate Chick spleen 310—625 10,000_*t
Human skin 105—210 830-1,665
Aureomycin HC1 & sod. glycinate Chick spleen 155-3 10 5, 000—
Human skin 105 210 830—1,250
Terramycin HCI & sod. glycinate Chick spleen 250—500 50,000*t
Human skin 50—100 520-1,040
Chloromycetin with glycine Chick spleen 125—250 2,500—5,000
Human skin 50—100 415—830
Endomycin Chick spleen 100—200 2,500 5,600
Human skin 50—100 250—500
Terramycin HC1 — —
Human skin 25—50 100—200
Gramicidin Chick spleen 5—10 500_*t
Human skin 0.1—0.2 0.5—1.0
* Higher concentrations could not be obtained due to low solubility.
t Marked inhibition, close to complete inhibition.
Partial inhibition.
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The results of these experiments are summarized in Tables I, II, III, and
Figures 1, 2, and 3. Approximately 1500 different cultures of chick spleen and
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4000 cultures of human skin were made in these determinations. Since penicillin
G sodium was employed as an antibacterial agent in all control experiments, it
has been listed as the first item in the tables. The other antibiotics are listed in
approximately the ascending order of their toxicity.
The data herewith recorded must be interpreted in terms of the conditions of
the experiment. For example, in the case of human epithelial explants, outgrowth
usually is not observed before the second or third day of incubation at 37°C;
it is possible and indeed probable that the decrease of the antibacterial effect of
certain antibiotics which takes place when they are in solution at room tempera-
ture is indicative of a significant change in the antibiotic. The results of the em-
bryonic chick spleen cultures were apparent in 24 hours, and therefore it is prob-
able that the deterioration factor was not significant in these experiments.
In general, the two important factors which seemed to influence the amount of
outgrowth from the tissue culture explants were the individual growth potential of
the tissue itself and the consistency of the clot. Usually, when the clot formation was
not firm, the outgrowth from the skin explant was reduced. On the other hand, in
the case of the embryonic chick spleen cultures, the migration was more diffuse
and extensive when the clot was semi-solid in consistency; this made it difficult
to establish a definite margin.
Some of these antibiotics are not stable in solution, and indeed there are other
variations in physical properties and behavior when they were incorporated in
the culture medium. Therefore, it is preferable to discuss separately the results
in the case of each antibiotic.
Penicillin
1. Penicillin G
Two different types of penicillin G were included in this study, penicillin
G sodium (Merck, Lot No. OTA 1157) and penicillin G potassium (buffered
crystal, Squibb, List 6736). No marked difference in toxicity was observed
except that the potassium salt was a little more toxic, as evidenced by its
MID of 2000—3750 (human skin explants) in contrast to that of 5000—10,000
for penicillin G sodium. Only penicillin G sodium was tested on spleen cul-
tures.
2. Penicillin 0 (Cer-O-Cillin or crystalline penicillin potassium, Upjohn,
AT 411)
This form of penicillin was less toxic for spleen cultures than penicillin G
sodium and slightly more toxic for human epithelial explants.
3. SKF-1714-J (experimental number for the diethylaminoethyl ester hydri-
odide of penicillin G, supplied by Smith, Kline & French Laboratories,
Philadelphia) Now available under trade name Neo-Penil.
The minimal inhibitory dose (MID) of this antibiotic could not be deter-
mined on account of its low solubility. The highest concentration obtained
was 2,500 gamma per ml., which resulted in only a small amount of out-
growth; this seemed to indicate that the level of complete inhibition (MID)
should not be far above this concentration. In the ease of spleen experiments,
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the highest concentration of the antibiotic obtainable was 5,000 gamma per
ml. of culture media, at which there was also a small amount of migration
close to complete inhibition.
These four preparations of penicillin were found to be of low toxicity for skin
cultures. The slight difference in the actual numerical values of their LID's and
MID's are considered to be of no significance and well within the range of tech-
nical error. However, SKF-1714-J was definitely more toxic for embryonic chick
spleen explants than penicillin G sodium and penicillin 0.
Bacitracin (Upjohn, X 6695)
The solubility of this antibiotic in water was of the order of magnitude of 40,000
gamma per ml. When such a solution was incorporated in medium suitable for
the cultivation of chick spleen, the highest concentration which could be ob-
tained was 20,000 gamma per ml. in the clot. This concentration did not inhibit
the migration of cells to a marked extent, and it is believed that a much higher
level would have been necessary for complete inhibition.
Neomycin (Neomycin sulfate, Upjohn, Res. No. 9273-2)
Neomycin has the valuable properties of high solubility in water, diffusibility
and stability in solution at room temperature or above for indefinite periods of
time.
Occasionally at concentrations of 6250 gamma per ml. of medium or higher,
the antibiotic appeared to interfere with the clotting mechanism.
Circulin (Antibiotic Q-19, Upjohn, Res. No. 8966-I, Assay 5000 units per mg.)
The MID for spleen tissue could not be obtained because concentrations es-
sential for complete inhibition could not be dissolved in the medium.
The mixture of all dilutions of the antibiotic with embryonic juice resulted in
a cloudy solution. It tended to precipitate out when mixed with plasma at con-
centrations of 830 gamma or more per ml. Despite this precipitation, it seemed to
diffuse fairly well, as evidenced by cheek experiments which were done with the
antibiotic incorporated in both the fluid and solid phase of the media.
$treptomycin (Merck, Calcium chloride complex, Lot. No. 2281)
The highest concentration of Streptomycin obtained in this particular prepara-
tion was 300,000 gamma per ml. of medium. In experiments on spleen, this con-
centration marked the borderline of marked to complete inhibition. Streptomycin
had a very wide range of toxicity on explants of spleen with a LID of 155-3 10
and a MID of approximately 300,000 gamma per ml. of media.
Chioromycetin
Two preparations of Chloromycetin, Chloromycetin Crystalline B (Parke
Davis, X 3928) and Chloromycetin Topical, which contains 10 mg. of Chioro-
mycetin and 100 mg. of glycine (Parke Davis, X 4772), were tested both on skin
and spleen cultures.
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Chioromycetin Crystalline B is soluble in water only to the extent of 0.6% at
60°C and less so at room temperature. The addition of glycine in the Chloromy-
cetin Topical preparation does not increase its solubility to any appreciable ex-
tent.
Both preparations were relatively diffusible, as shown by check experiments
utilizing Chloromycetin in both the fluid and solid phase of the media. Additional
control cultures made with glycine indicated that its presence should not have
affected the toxicity of Chioromycetin significantly.
Polymyxin B Sulfate (Aerosporin, Burroughs Welicome, V-280, P 341)
In all dilutions, there was a tendency for Polymyxin B Sulfate to form a milky
and cloudy solution when mixed with embryonic juice. However, this did not
seem to interfere with its free diffusion in the medium.
Because of the limited solubility, 10,000 gamma per ml. of medium was the
highest concentration obtained. With this concentration, there was minimal
migration of cells from explants of spleen, and therefore it is probable that the
MID of Polymyxin B Sulfate for spleen tissue is slightly more than 10,000 gamma
per ml.
Aureomycin (Aureomycin hydrochloride, intravenous, buffered with sodium
glycinate, Lederle, Lab. No. 7-5964)
Aureomycin presented considerable difficulty due to its tendency to precipi-
tate. Following storage under "deep freeze" conditions, an aqueous solution which
had been perfectly clear showed sedimentation upon thawing. Precipitation was
noted in every case when clear solutions were mixed with embryonic juice. How-
ever, it did diffuse into the fluid phase of the medium. At a higher concentration
(830 gamma per ml.), this precipitation affected the clot formation so that liquid
or semi-solid cultures resulted.
Due to its relatively low solubility, the highest concentration obtained in the
culture medium of chick spleen was 5000 gamma per ml., which caused marked
(almost complete) inhibition of migration of splenic cells.
Terramycin
The crystalline Terramycin hydrochloride (Pfizer) is readily soluble iii water,
forming a clear solution, but within a few minutes precipitation takes place. To
obviate this disadvantage insofar as possible, only fresh solutions prepared
immediately before incorporation in the plasma were used in our experiments.
Despite this, in high concentrations, it precipitated out when the plasma con-
taining the antibiotic was mixed with the embryonic juice.
Another preparation which was used was Terramycin hydrochloride buffered
with sodium glycinate (Pfizer, Lot WKD 507678). The presence of sodium glyc-
mate increased the solubility of Terramycin markedly and also prevented the
precipitation. However, in concentrations of 1,040 gamma per ml. or higher,
precipitation occurred on mixture with the embryonic juice; this sequence of
events did not interfere with the results of the experiment. Check experiments
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indicated that it diffused freely in the fluid and clot phase. To some extent, it
tended-to interfere with the clot formation when the concentration was 12,500
gamma per ml. or more.
The maximum concentration (50,000 gamma per ml. of medium) of Terra-
mycin hydrochloride buffered with sodium glycinate which was possible caused
almost complete inhibition of migration of splenic cells.
Endomycin (Upjohn, Res. No. 9487)
Endomycin dissolved freely in water. However, it tended to precipitate out
when incorporated into the culture medium at concentrations of 1,000 gamma or
more per ml. There was interference with clot formation with concentrations
above 250 gamma per ml. Check experiments indicated that it diffused uniformly
in the culture medium.
Penicillin G sodium in a concentration of 1000 gamma per ml., which was the
same amount used in the control skin cultures, was added in all cultures because
Endomycin alone did not prevent bacterial contamination. It is probable that
the addition of penicillin G sodium to the medium did not increase the toxicity
of the Endomycin. Previous experience with the use of two antibiotics, such as
Aureomycin and penicillin or Neomyciri and penicillin, in their non-toxic con-
centrations, indicated that the combination of two antibiotics does not enhance
the toxic effect of either one.
Gram'icidin (Smith, Kline & French Laboratories, Lot #32650)
This antibiotic is insoluble in water. Although it is quite soluble in ethyl
alcohol, it precipitates out when water is added to the alcoholic solution. The
stock solution used for this study has a concentration of 2000 gamma per ml. of
60% alcohol. Any increase in the amount of Gramicidin with or without increase
of concentration of the solvent results in the precipitation of the antibiotic when
diluted with water or Gey's balanced salt solution.
Parallel experiments, using the same concentrations of alcohol as those con-
tained in different dilutions of Gramicidin solutions, were done as additional
controls. The LID of alcohol on spleen was determined to be from 1:400 to 1 :200
and the MID of the order of magnitude of about 1:4. Therefore, it is probable
that the concentrations of alcohol (1:660—1:330) in the Gramicidin solution did
not affect the LID of Gramicidin. The presence of 1:6.6 alcohol, which was the
amount of alcohol in the MID concentration of Gramicidin, resulted in a signif-
icant toxic effect on the splenic cells; it may be assumed that the combination of
alcohol and Gramicidin does increase the toxicity of that particular concentra-
tion of Gramicidin. Therefore its MID is not to be considered accurate. With
human skin, the LID and MID of alcohol were found to be 1:480—1:240 and
1: 12 respectively; since the concentrations of alcohol in the Gramicidin solution
(1:33,200, 1:16,600, 1:6,640, and 1:3,320) were far below the toxic level, its
presence should not have increased the toxicity of Gramicidin.
Determinations of the pH of the stock solutions of the antibiotics were done
at least two or more times; the results are recorded in Table IV. Correlation of
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the in vitro toxicity of the various antibiotics and the pH of the solutions makes
it obvious that the difference in pH was not a decisive factor in determining the
relative toxicity. For example, SKF-1714-J, which has a range of pH 3—4.6,
TABLE IV
pH Values of the stock solutions of antibiotics
ANTIBIOTIC % OF STOCK SOLUTION' AVERAGE pH REMARKS
Penicillin G Sodium
Penicillin G Potassium
12
6
6
4.35
5.05
4.4
Bacitracin 2 6.3
Neomycin sulfate 20 4.7
10 5.0
5 4.7
SKF-1714-J (Neo-Penil) 1 3.8
Penicillin 0 6 4.3
Circulin 2 4.3
1 4.3
Streptomycin 50 4.5
20 3.6
Chioromycetin 0.6 6.9
Polymyxin B Sulfate 2 6.5
Aureomycin HC1 & sodium gly- 1 Precipitate after freez-
cinate I ing
Terramycin & sodium glycinate 5 9.5
Chioromycetin & glycine 1 6.5
Endomycin 2.5 6.1
Terramycin HC1 0.5 2.7 Precipitate on standing
Gramicidin 0.2 6.7
in 60% alcohol
was not more toxic than Bacitracin, which has a pH of 6.3, while Chioromycetin
and Aureomycin, which have a pH of 6.9 and 7.2 respectively, were more toxic
than SKF-1714-J. (Neo-Penil)
It is interesting to note and significant that Terramycin hydrochloride solution
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with a pH of 2.7 was more toxic for explants of human skin than solution of
Terramycin hydrochloride buffered with sodium glycinate with a pH of 9.5;
this is the only antibiotic which was studied in this manner. Terramycin hydro-
chloride was the sole antibiotic in this group which resulted in a solution with
the pH lower than 3.5.
TABLE V
Grouping according to the retative toxicity of various antibiotics to the explants of skin
and spleen
SKIN SPLEEN
Group I (LID 415—1,665) Group I (LID 625—5,000)
(MID 2000—10,000) (MID 75000—500000)
Penicillin G Neomycin
Bacitracin Penicillin 0
Neomycin Penicillin G
SKF-1714-J (Neo-Penil) Circulin
Penicillin 0 Bacitracin
Circulin
Intermediate Group (between Groups I and II)
Streptomycin Streptomycin
Terramycin & sod. glycinate
Group II (LID 105—415) Group II (LID 125—625)
(MID 415—1665) (MID 5000—20000)
Polymyxin Polymyxin
Aureomycin Aureomycin
SKF-1714-J (Neo-Penil)
Intermediate Group (between Groups II and III)
Tarramycin & sod. glycinate Chloromycetin & glycine
Chloromycetin & glycine Chloromycetin
Chloromycetin
Group III (LID 50—100) Group III (LID 100—330)
(MID 250—500) (MID 1665—5000)
Endomycin Endomycin
Group IV (LID 0.1—0.2) Group IV (LID 5—10)
(MID 0.5—1.0) (MID 500—1000)
Gramicidin Gramicidin
The relative order of toxicity of these thirteen antibiotics differs slightly when
the data in regard to human skin are compared with the results with embryonic
chick spleen tissue. Also, in some cases, the relative order varies when the LID
results are compared with the MID results. If one considers the MID and LID
for both human skin and embryonic chick spleen, it becomes apparent that the
relative toxicity is best expressed by grouping together those antibiotics which
have about the same degree of in vitro toxic effect. These results are summarized
in Table V and are self-explanatory. It is obvious that the penicillin preparations,
TISSUE CULTURE STUDIES ON HUMAN SK1N 369
Bacitracin, Neomycin, and Circulin are unusually non-toxic and that Gramicidin
is very toxic; Endomycin is more toxic than all other antibiotics tested except
for Gramicidin. The other antibiotics occupy an intermediate position in the
scale of toxicity.
DISCUSSION
The fact that it is possible to maintain adult human epithelium in a viable
state with significant outgrowth of epithelial cells for as long as eight to ten days
opens up a new field of investigation with many facets. One possible practical
application is the development of a laboratory method for the evaluation of new
therapeutic agents in respect to their potential toxic or primary irritant effect
on skin and mucous membranes. If there is a relatively uniform, distinct corre-
lation of these laboratory data with what happens in actual practice, it would
he possible to avoid the "trial and error" clinical evaluation which is time con-
suming and, for obvious reasons, not ideal.
It is not possible for us to state without reservation that the results obtained
in these tissue culture experiments may be correlated directly with the compara-
tive degree of primary irritation which may be expected when varying percent-
ages of the antibiotics are applied to intact and diseased skin. It is very difficult
to collect data which make it possible to grade topical medicaments from the
standpoint of their primary irritant capacity when there is relatively little
difference in this effect. Experiments which were designed to determine the
primary irritant concentration of each antibiotic for intact skin were most in-
complete and of little value because of solubility problems, and furthermore,
the "primary irritant dose" varied considerably from person to person. We are
continuing these studies with the hope that the use of other vehicles and a
modified technic will facilitate this method of evaluation.
Symth and his co-workers (22, 23) have recommended the use of the so-
called rabbit eye test for the evaluation of the potential primary irritant capacity
of chemicals; antibiotics were not included in their studies. We have not con-
ducted such experiments, but work which has been done in the laboratories of
the Upjohn Company (24) indicates that 3% Bacitracin and 3% Neomycin
does not cause primary irritation of the conjunctiva of the rabbit's eye whereas
1% Endomycin causes marked irritation. One per cent Polymyxin B Sulfate
solution is said to be irritating (25) when applied to the eye, but 0.1% is not
irritating. flamed (26) reported mild irritation of the human eye following
the continued instillation of 0.5% solution of Aureomycin eye drops.
Perhaps it is pertinent to note that the concentration of Aureomycin, Terra-
mycin, and Chloromycetin which is recommended for instillation in the human
eye for treatment of bacterial infections is 0.5%.
We have had no clinical experience with Gramicidin, but it is interesting to
note that two commerical preparations (nose drops) use an extremely low con-
centration of the antibiotic (0.005%). Also two commercially prepared oint-
ments containing Gramicidin, either alone or in combination with another
antibiotic, use a very small concentration (0.25 mgs. per gm.—0.025%).
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If all of these data are summarized, it is apparent that there is general agree-
ment that Gramicidin is the most toxic antibiotic now available; and also, on
the other side of the scale, it is well established that comparatively high concen-
trations of penicillin, Neomycin, and Bacitracin do not cause primary irritation
when applied to normal and diseased skin and mucous membranes. We have had
no experience with the use of Circulin; and the primary irritant concentration
of this antibiotic for the rabbit's eye has not been reported. There has been very
little clinical experience with Endomycin.
It does not seem justifiable to state that there is any detectable difference in
the potential or actual primary irritant effect of the other antibiotics which are
included in this study, namely, Streptomycin, Terramycin, Polymyxin B Sul-
fate, and Aureomycin. However, it does seem significant that the manufac-
turers of these antibiotics do not recommend the use of a concentration greater
tban 0.5% for treatment of eye conditions.
Smyth and his co-workers of the Mellon Institute of Industrial Research
(University of Pittsburgh) have had a very extensive experience in regard to the
evaluation of chemicals used in industry from the standpoiut of potential prim-
ary irritant effects on the skin and mucous membranes of workers who might be
exposed. In a personal communication, Dr. Smyth has summarized the present
status of available methods as follows, "We have several times attempted to
distinguish between consecutive batches of materials intended for topical ap-
plication where differences in irritation were very slight. We have tried trypan
blue and fluorescein injection methods, skin temperature and transmission of
green light by rabbit ear, all to no avail. We conclude that we are unable to dis-
criminate reliably between substantially identical degrees of primary irritation
to epithelium. As a matter of fact, we have felt that the only recourse would be
tissue culture."
When incorporated in the plasma clot medium, the behavior of some of these
antibiotics as regards precipitation, interference with clot formation, etc. de-
serves comment. It is possible that these phenomena may modify the in vitro
toxic effect of some of these antibiotics. On the other hand, it is probable that
similar circumstances prevail when these antibiotics come in contact with serous
exudate when they are used in the local treatment of cutaneous pyogenic infec-
tions. Perhaps practical hints for clinical application may be drawn from these
in vitro experiments, over and above the accumulation of data regarding the
relative toxicity of the antibiotics which were studied.
It will be most difficult to prove conclusively that the relative order of toxicity
of medicaments as determined by tissue culture experiments with human skin
explants corresponds exactly with the in vivo primary irritant effect on normal
and diseased skin and mucous membrane. However, our experience to date
indicates quite clearly that there is gross correlation. It follows that the deter-
mination of the toxic dose of an agent for epithelial cells (and probably other
tissues) makes it possible to predict that the drug is apt to be very irritant,
moderately irritant, comparatively non-irritant, or essentially non-irritant.
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SUMMAEY
1. The Comparative toxic effect of 13 antibiotics for explants of adult hnman
skin and embryonic chick spleen growing in tissue culture is reported; approx-
imately 5500 cultures were done in the accumulation of these data.
2. There was a very wide range in toxic effect of the different antibiotics; the
most toxic one, Gramicidin, inhibited growth of skin explants in a concentration
of 1 meg. per ml. whereas the least toxic antibiotics, Neomycin, Bacitracin,
and penicillin 0 sodium, caused similar complete inhibition only when the
concentrations were of the order of 4,165 to 10,000 mcgs.
3. Other antibiotics which were studied exhibited varying degrees of toxicity,
which are discussed in detail.
4. The rather close correlation between these in vitro results and the in vivo
effects of these antibiotics when applied to the skin and mucous membranes is
discussed.
5. This method is proposed as a possible laboratory procedure for "scout"
testing of new therapeutic agents in respect to potential capacity for causing
minimal to gross irritation on topical application to skin and mucous membranes.
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DISCUSSION
DR. J. WALTER WILSON, Los Angeles, Calif.: I noted there were some dis-
crepancies here and I hope these are within the limits of experimental error,
because Aureomycin and Terramycin may be derivatives of the same substance
of which Aureomycin is probably the chloride and Terramycin the hydroxide.
In many observations there is great similarity in the reaction of these two com-
pounds; we know that it has been reported that those organisms which are
resistant to one also are resistant to the other. Their solubilities, toxicities and
the ability to induce moniliasis are also very similar.
DR. C. S. LIVINGOOD, Galseston, Texas (in closing): The data which we have
collected to date do not justify the premise that there is complete correlation
between the toxic effects of antibiotics (and other drugs) for cells in tissue culture
and the comparative primary irritant effects when they are applied to skin and
mucous membrane. It will be most difficult to prove this point because it is
almost impossible to determine the exact comparative primary irritant effects
of drugs which do not show considerable variation in this respect. However, it
would seem that this is a promising laboratory method which has a probable
practical application in the evaluation of new drugs which are intended for
topical application to the skin and mucous membranes.
